Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 2. Selank has published papers and no verified intervention trial.
Loading filters…
BPC-157
2011
Publication
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.
Chang CH et al. · Journal of Applied Physiology
PublishedSame compound as the catalogue listing
Preclinical paper. The title is the authors' wording, not a Nalen Lab claim.
View in the catalogueBPC-157
2003
Publication
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.
Staresinic M et al. · Journal of Orthopaedic Research
PublishedSame compound as the catalogue listing
Rat and in-vitro experiments.
View in the catalogueBPC-157
2016
Publication
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.
Sikiric P et al. · Current Neuropharmacology
PublishedSame compound as the catalogue listing
Review.
View in the catalogueBPC-157
2021
Publication
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
Seiwerth S et al. · Frontiers in Pharmacology
PublishedSame compound as the catalogue listing
Review.
View in the catalogueBPC-157
2026
Registry
BPC 157 for Acute Hamstring Muscle Strain Repair
Phase 2 · ClinicalTrials.gov · NCT07437547 · Hudson Biotech
RecruitingSame compound as the catalogue listing
Registry record checked 21 November 2026. A registration is not a result. Status can change; the link is the source of truth.
View in the catalogueBPC-157
2026
Registry
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery
Phase 1 · ClinicalTrials.gov · NCT07803250 · University of Arkansas
Not yet recruitingSame compound as the catalogue listing
Listed start date 1 January 2027. Not yet recruiting when checked on 21 November 2026.
View in the catalogueBPC-157
2015
Registry
PCO-02 - Safety and Pharmacokinetics Trial
Phase 1 · ClinicalTrials.gov · NCT02637284 · PharmaCotherapia d.o.o.
UnknownSame compound as the catalogue listing
Official title names BPC-157 (Bepecin) as the active ingredient of oral PCO-02. ClinicalTrials.gov status is Unknown. Last update posted December 2015. Not counted as an active trial.
View in the catalogue